| Date | Event |
| 3-Nov-09 | Anadys Pharma upgraded by Piper Jaffray |
| 30-Oct-09 | ANADYS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report |
| 29-Oct-09 | Anadys Pharmaceuticals, Inc. Earnings Call scheduled for 5:00 pm ET today |
| 29-Oct-09 | ANADYS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an |
| 31-Jul-09 | ANADYS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report |
| 30-Jul-09 | Anadys Pharmaceuticals, Inc. Earnings Call scheduled for 5:00 pm ET today |
| 30-Jul-09 | ANADYS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an |
| 8-Jul-09 | Price hit new 52-week low ($1.44) |
| 24-Jun-09 | ANADYS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement |
| 4-Jun-09 | ANADYS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Pri |
| 24-Apr-09 | ANADYS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report |
| 23-Apr-09 | ANADYS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an |
| 3-Mar-09 | ANADYS PHARMACEUTICALS INC Files SEC form 10-K, Annual Report |
| 26-Feb-09 | ANADYS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an |
| 20-Feb-09 | Price hit new 52-week high ($8.43) |
| 19-Feb-09 | Price hit new 52-week high ($7.57) |
| 18-Feb-09 | Price hit new 52-week high ($7.13) |
| 13-Jan-09 | ANADYS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers |
| 31-Dec-08 | Price hit new 52-week low ($1.50) |